Pilot Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML

Trial Profile

Pilot Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML

Discontinued
Phase of Trial: Phase II

Latest Information Update: 22 Sep 2017

At a glance

  • Drugs Cytarabine (Primary) ; Vosaroxin (Primary)
  • Indications Acute myeloid leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Aug 2017 Status changed from suspended to discontinued.
    • 24 Aug 2016 Status changed from recruiting to suspended.
    • 01 Dec 2015 Status changed from not yet recruiting to recruiting according to a Sunesis Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top